Hostname: page-component-77c89778f8-cnmwb Total loading time: 0 Render date: 2024-07-23T03:51:26.299Z Has data issue: false hasContentIssue false

FKBP5 Modulates the Effects of Nicotine on Hpa Axis Activity in Females

Published online by Cambridge University Press:  23 March 2020

F. Kiefer
Affiliation:
Department of Addictive Behaviour and Addiction Medicine Mannheim, Central Institute of Mental health, Mannheim, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background

FK506 binding protein 51 is a modulator of the hypothalamic-pituitary-adrenal axis activity. Its function is modulated by the single nucleotide polymorphism rs 1360780. Females often use smoking to cope with stress. The aim of this study was to investigate if the influence of nicotine consumption on cortisol plasma levels is modified by the polymorphism of rs 1360780 in females.

Methods

Two hundred and ninety-six female smokers were genotyped for the SNP rs1360780 of FKBP5 protein. Cortisol plasma concentrations were measured in blood plasma drawn three hours after smoking. Severity of tobacco addiction was assessed based on the Fagerström Test for Nicotine Dependence (FTND).

Results

Thirty-six participants were TT-homozygotes and 260 were C allele carriers. In TT homozygotes, we found a significant negative correlation between the FTND sum score and the cortisol plasma concentrations. In a linear regression analysis, the FTND sum score accounts for 12.4% of the variance of cortisol plasma levels. By contrast, we could not find such an association in C allele carriers.

Conclusions

Our results suggest that nicotine is an important confounder in the modulation of HPA axis activity by FKBP5. In the light of these findings, future studies on FKBP5 should include nicotine consumption as a confounder.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster walk: Substance related and addictive disorders–part 1
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.